| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/01/2013 | CN103079529A Vesicle composition, and external skin preparation and cosmetic, each containing same |
| 05/01/2013 | CN103073730A CA-(PLA-ran-PLC-b-PEC) periodic copolymer and preparation method and application thereof |
| 05/01/2013 | CN103073726A Block copolymer, liquid composition, nucleic acid preparation, and preparation methods and applications thereof |
| 05/01/2013 | CN103073646A Polypeptide carrying melittin, nano-particles carrying melittin, and applications thereof |
| 05/01/2013 | CN103071161A Preparation method of polycationic liposome/calcium phosphate nanoparticle drug delivery vector |
| 05/01/2013 | CN103071159A Preparation method and application of adriamycin-polypeptide compound and pharmaceutical composition |
| 05/01/2013 | CN103071158A Bone capsule shell with functions of supplying calcium and building strong bones and preparation method thereof |
| 05/01/2013 | CN103071157A Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders |
| 05/01/2013 | CN103071156A Chitosan wrapped negatively-charged gold nanoparticle, and preparation method and application thereof |
| 05/01/2013 | CN103071155A Graphene oxide surface-enhanced Raman scattering positioning drug carrier and preparation method thereof |
| 05/01/2013 | CN103071146A Caspofungin acetate composition and preparation method thereof |
| 05/01/2013 | CN103070956A Biological adhesion colon positioning micro-chip for treating ulcerative colitis |
| 05/01/2013 | CN103070936A Penetration enhancer and application of penetration enhancer in permeation enhancement |
| 05/01/2013 | CN103070917A Novel leonurus capsule and preparation method thereof |
| 05/01/2013 | CN103070913A Penetration enhancer composition and application of penetration enhancer composition in permeation enhancement |
| 05/01/2013 | CN103070898A Salvia miltiorrhiza and panax notoginseng compound nano suspension |
| 05/01/2013 | CN103070894A 阿魏微囊漂浮片及其制备方法 Ferulic microcapsules floating tablet and its preparation method |
| 05/01/2013 | CN103070889A Periplaneta americana extract cream and preparation method thereof |
| 05/01/2013 | CN103070887A Modified snake venom gelling agent and preparation method thereof |
| 05/01/2013 | CN103070874A Minodronic acid hydrate medicine composition |
| 05/01/2013 | CN103070871A Pharmaceutical composition of fulvestrant |
| 05/01/2013 | CN103070856A Composition containing andrographolidi natrii bisulfis and preparation method and application thereof |
| 05/01/2013 | CN103070852A Calcium and zinc gluconate liposome oral solution |
| 05/01/2013 | CN103070848A Losartan potassium gastric floating capsule and preparation method thereof |
| 05/01/2013 | CN103070847A Method for preparing docusate sodium soft capsules |
| 05/01/2013 | CN103070846A Docusate sodium soft capsule |
| 05/01/2013 | CN103070845A Starch hollow capsule and preparation method thereof |
| 05/01/2013 | CN103070844A Locating quick-release biological adhesive and application thereof |
| 05/01/2013 | CN103070842A Preparation method of miglitol sustained release tablet |
| 05/01/2013 | CN103070840A Oxycodone hydrochloride slow release dripping pills and preparation method thereof |
| 05/01/2013 | CN103070839A Sitafloxacin tablet and preparation method thereof |
| 05/01/2013 | CN103070838A Solid dosage form comprising solid dispersion and method for producing the same |
| 05/01/2013 | CN103070837A Triptorelin Acetate slow release dripping pills |
| 05/01/2013 | CN103070836A Ciclesonide nanometer freeze-dried powder and preparation method thereof |
| 05/01/2013 | CN103070835A Freeze-dried composition containing bortezomib and preparation method of freeze-dried composition |
| 05/01/2013 | CN103070834A Lyophilized powder containing esomeprazole |
| 05/01/2013 | CN103070833A Freeze-dried powder injection of propionyl-L-carnitine hydrochloride and preparation method of freeze-dried powder injection |
| 05/01/2013 | CN103070832A Cisatracurium besylate lyophilized preparation composition stable at room temperature and preparation method thereof |
| 05/01/2013 | CN103070831A Method for preparing 10-90% folic acid granules |
| 05/01/2013 | CN103070830A Production method for 20-percent tilmicosin granules |
| 05/01/2013 | CN103070829A Medicine composition including pramipexole and active ingredients of medicinal salt and preparation method thereof |
| 05/01/2013 | CN103070828A Solid dispersion and tablets comprising abiraterone acetate, and preparation methods thereof |
| 05/01/2013 | CN103070824A Ibandronate sodium containing injection |
| 05/01/2013 | CN103070822A Argatroban injection and preparation method thereof |
| 05/01/2013 | CN103070390A Nano-liposome carrier composition and preparation method thereof |
| 05/01/2013 | CN102614145B Stable febuxostat tablet and preparation method thereof |
| 05/01/2013 | CN102600099B Method for preparing sinomenine hydrochloride sustained release tablets by non-organic solvents |
| 05/01/2013 | CN102552932B Method for preparing graphene oxide double-targeting medicine carrier material, and loaded medicine |
| 05/01/2013 | CN102552136B Propofol medium/long-chain injection and preparation method thereof |
| 05/01/2013 | CN102526000B Dexibuprofen slow-release capsule and production method thereof |
| 05/01/2013 | CN102525938B Minocycline hydrochloride nano calcium carbonate preparation and preparation method thereof |
| 05/01/2013 | CN102512399B Long-acting naltrexone implant and preparation method thereof |
| 05/01/2013 | CN102440972B Gliclazide tablet (II) and preparation method thereof |
| 05/01/2013 | CN102429862B Sustained-release povidone iodine eye drops |
| 05/01/2013 | CN102415991B Enrofloxacin long-acting injection and preparation method thereof |
| 05/01/2013 | CN102408560B Preparation method of environment response type radial copolymer |
| 05/01/2013 | CN102363040B Antimicrobial peptide preparation for mucosal tissues |
| 05/01/2013 | CN102319210B Veterinary long-acting cefquinome sulfate injection and preparation method thereof |
| 05/01/2013 | CN102302514B Pig blood deproteinized extract gel and preparation method thereof |
| 05/01/2013 | CN102293997B Preparation method of dried ginger extract |
| 05/01/2013 | CN102293735B Antifungal imidazole medicament controlled-release gel and preparation method thereof |
| 05/01/2013 | CN102266293B Ambroxol hydrochloride sustained-release dry suspension and preparation method thereof |
| 05/01/2013 | CN102233130B Stable pharmaceutical preparation containing thymosin 1 derivatives |
| 05/01/2013 | CN102166201B Oral ciclosporin A sustained-release agent and preparation method thereof |
| 05/01/2013 | CN102161712B Method for preparing micromolecule pectin |
| 05/01/2013 | CN102100758B Qingpeng gel for relieving pain and subdhing swelling and preparation method thereof |
| 05/01/2013 | CN102058535B Novel folate receptor targeted liposome |
| 05/01/2013 | CN102051702B Mesoporous silicon oxide particle/degradable polymer nano composite fiber, preparation method and application thereof |
| 05/01/2013 | CN102048680B Enteric sustained-release preparation containing zaltoprofen and preparation method thereof |
| 05/01/2013 | CN102018953B Pharmaceutical composition containing nocathiacin antibiotics |
| 05/01/2013 | CN101816637B 来氟米特片制剂及其制备方法 Leflunomide tablets and its preparation method |
| 05/01/2013 | CN101810586B L-dopa methyl ester sustained-release microsphere composite and preparation method thereof |
| 05/01/2013 | CN101732697B Compound frozen ossotide preparation |
| 05/01/2013 | CN101683522B Novel albumin-free factor VIII formulations |
| 05/01/2013 | CN101432383B Nonaqueous pressure-sensitive adhesive composition, patches and process for production of patches |
| 05/01/2013 | CN101332237B Traditional Chinese medicine composition for treating the prostatitis and preparation method thereof |
| 04/30/2013 | US8431685 Polymer-based sustained release device |
| 04/30/2013 | US8431619 Aqueous composition for cosmetics and cosmetic including the same |
| 04/30/2013 | US8431618 Processed starch powder with excellent disintegration properties and manufacturing method thereof |
| 04/30/2013 | US8431545 Copolymer including uncharged hydrophilic block and cationic polyamino acid block having hydrophobic group in part of side chains, and use thereof |
| 04/30/2013 | US8431537 Glue composition for lung volume reduction |
| 04/30/2013 | US8431534 GRF-containing lyophilized pharmaceutical compositions |
| 04/30/2013 | US8431380 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/30/2013 | US8431159 Solid pharmaceutical dispersions with enhanced bioavailability |
| 04/30/2013 | US8431154 Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient |
| 04/30/2013 | US8431143 Therapeutic method of administering pharmaceutical titanium dioxide composite and light irradiation |
| 04/30/2013 | US8431124 Methods for treating a disease characterized by an excess of hyaluronan by administering a soluble hyaluronidase glycoprotein (sHASEGP) |
| 04/30/2013 | US8431121 Specifically targeted catalytic antagonists and uses thereof |
| 04/30/2013 | US8431113 Polymer conjugates |
| 04/30/2013 | CA2730627C Human and mouse targeting peptides identified by phage display |
| 04/30/2013 | CA2713727C Carrageenan modified by ion-exchange process |
| 04/30/2013 | CA2698327C Pharmaceutical product comprising yeast |
| 04/30/2013 | CA2662919C Pharmaceutical compositions containing rosuvastatin calcium |
| 04/30/2013 | CA2602089C Tigecycline compositions and methods of preparation |
| 04/30/2013 | CA2540869C Spill resistant formulations containing clays |
| 04/30/2013 | CA2531023C Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
| 04/30/2013 | CA2458995C Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
| 04/30/2013 | CA2399321C Adenovirus formulations |
| 04/30/2013 | CA2365742C Formulations for amylin agonist peptides |
| 04/25/2013 | WO2013059702A1 Cerivastatin to treat pulmonary disorders |